This inventor holds 9 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents. Top assignees: Epix Delaware, Inc., Cytopathfinder, Inc., Nanotherapeutics, Inc.. Active years: 2006-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2006-2013
Title: Innovations and Contributions of Pradyumna Mohanty
Introduction
Pradyumna Mohanty is a notable inventor based in Woburn, MA, with a significant portfolio of nine patents. His work primarily focuses on pharmaceutical compounds and their applications in treating various medical conditions.
Latest Patents
Among his latest patents, Mohanty has developed carboxamide compounds that act as antagonists of the chemokine CCR2 receptor. These compounds are particularly useful in treating or preventing diseases associated with the accumulation of monocytes, lymphocytes, or leukocytes. Another significant patent involves thienopyridinone compounds, which serve as 5-HT receptor agonists and partial agonists. These novel compounds are aimed at treating a range of conditions, including Alzheimer's disease, cognition disorders, and various gastrointestinal and psychological disorders.
Career Highlights
Throughout his career, Mohanty has worked with prominent companies such as Epix Delaware, Inc. and Nanotherapeutics, Inc. His contributions to the field of pharmaceuticals have been instrumental in advancing treatment options for numerous health issues.
Collaborations
Some of his notable coworkers include Dongli Chen and Yael Marantz, who have collaborated with him on various projects and research initiatives.
Conclusion
Pradyumna Mohanty's innovative work in the pharmaceutical industry has led to the development of important compounds that address critical health challenges. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile